Rapid communication Open Access
Like 0


Until recently, children and adolescents were not eligible for COVID-19 vaccination. They may have been a considerable source of SARS-CoV-2 spread. We evaluated SARS-CoV-2 IgG antibody seroprevalence in Israeli children aged 0–15 years from January 2020 to March 2021. Seropositivity was 1.8–5.5 times higher than COVID-19 incidence rates based on PCR testing. We found that SARS-CoV-2 infection among children is more prevalent than previously thought and emphasise the importance of seroprevalence studies to accurately estimate exposure.


Article metrics loading...

Loading full text...

Full text loading...



  1. Radtke T, Ulyte A, Puhan MA, Kriemler S. Long-term symptoms after SARS-CoV-2 infection in children and adolescents. JAMA. 2021;326(9):869.  https://doi.org/10.1001/jama.2021.11880  PMID: 34264266 
  2. Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626-31.  https://doi.org/10.1038/s41591-021-01292-y  PMID: 33692530 
  3. Zhu Y, Bloxham CJ, Hulme KD, Sinclair JE, Tong ZWM, Steele LE, et al. A meta-analysis on the role of children in severe acute respiratory syndrome coronavirus 2 in household transmission clusters. Clin Infect Dis. 2021;72(12):e1146-53.  https://doi.org/10.1093/cid/ciaa1825  PMID: 33283240 
  4. Almadhi MA, Abdulrahman A, Sharaf SA, AlSaad D, Stevenson NJ, Atkin SL, et al. The high prevalence of asymptomatic SARS-CoV-2 infection reveals the silent spread of COVID-19. Int J Infect Dis. 2021;105:656-61.  https://doi.org/10.1016/j.ijid.2021.02.100  PMID: 33647516 
  5. Isreal Ministry of Health. COVID-19 daily situation report. Ramat-Gan: Isreal Ministry of Health; 2021. [Accessed: 3 Nov 2021]. Available from: https://datadashboard.health.gov.il/COVID-19/general
  6. Bassal R, Cohen D, Green MS, Keinan-Boker L. The Israel national sera bank: methods, representativeness, and challenges. Int J Environ Res Public Health. 2021;18(5):2280.  https://doi.org/10.3390/ijerph18052280  PMID: 33668988 
  7. Israel Central Bureau of Statistics (CBS). Characterization and classification of local authorities by the socio-economic level of the population in 2015. Jerusalem: CBS; 2021. Available from: https://din-online.info/pdf/lst92e.pdf
  8. Indenbaum V, Koren R, Katz-Likvornik S, Yitzchaki M, Halpern O, Regev-Yochay G, et al. Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosis. PLoS One. 2020;15(11):e0241164.  https://doi.org/10.1371/journal.pone.0241164  PMID: 33227020 
  9. Oved K, Olmer L, Shemer-Avni Y, Wolf T, Supino-Rosin L, Prajgrod G, et al. Multi-center nationwide comparison of seven serology assays reveals a SARS-CoV-2 non-responding seronegative subpopulation. EClinicalMedicine. 2020;29:100651.  PMID: 33235985 
  10. Lustig Y, Sapir E, Regev-Yochay G, Cohen C, Fluss R, Olmer L, et al. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers. Lancet Respir Med. 2021;9(9):999-1009.  https://doi.org/10.1016/S2213-2600(21)00220-4  PMID: 34224675 
  11. United States Food and Drug Administration (FDA). Coronavirus (COVID-19) update: FDA authorizes Pfizer-BioNTech COVID-19 vaccine for emergency use in adolescents in another important action in fight against pandemic. Silver Spring: FDA; 2021. Available from: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use
  12. European Medicine Agency (EMA). First COVID-19 vaccine approved for children aged 12 to 15 in EU. 2021. Amsterdam: EMA; 2021. Available from: https://www.ema.europa.eu/en/news/first-covid-19-vaccine-approved-children-aged-12-15-eu
  13. United States Food and Drug Administration (FDA). Vaccines and Related Biological Products Advisory Committee October 26, 2021 Meeting Announcement. Silver Spring: FDA; 2021. Available from: https://www.fda.gov/news-events/press-announcements/fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use-children-5-through-11-years-age
  14. European Medicine Agency (EMA). Comirnaty COVID-19 vaccine: EMA recommends approval for children aged 5 to 11. Amsterdam: EMA; 2021. Available from: https://www.ema.europa.eu/en/news/comirnaty-covid-19-vaccine-ema-recommends-approval-children-aged-5-11.
  15. Bobrovitz N, Arora RK, Cao C, Boucher E, Liu M, Donnici C, et al. Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis. PLoS One. 2021;16(6):e0252617.  https://doi.org/10.1371/journal.pone.0252617  PMID: 34161316 
  16. Brotons P, Launes C, Buetas E, Fumado V, Henares D, de Sevilla MF, et al. Susceptibility to severe acute respiratory syndrome coronavirus 2 infection among children and adults: a seroprevalence study of family households in the Barcelona Metropolitan Region, Spain. Clin Infect Dis. 2021;72(12):e970-7.  https://doi.org/10.1093/cid/ciaa1721  PMID: 33180914 
  17. Zalcberg S, Block SZ. COVID-19 Amongst the Ultra-Orthodox Population in Israel: An Inside Look into the Causes of the High Morbidity Rates. Contemp Jew. 2021;41(1):1-23.  https://doi.org/10.1007/s12397-021-09368-0  PMID: 34305203 
  18. Yang Y, Wang X, Du RH, Zhang W, Si HR, Zhu Y, et al. Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses. Emerg Microbes Infect. 2021;10(1):905-12.  https://doi.org/10.1080/22221751.2021.1919032  PMID: 33870851 

Data & Media loading...

Submit comment
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error